Study on the Mechanism of Atractylodes lancea in the Treatment of Diabetes Based on Network Pharmacology

2020-09-01 01:57:20WeiboDAIWeiwenPENGXiwenZHONGLeyuLI
Medicinal Plant 2020年4期

Weibo DAI, Weiwen PENG, Xiwen ZHONG, Leyu LI

Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan 528400, China

Abstract [Objectives] To predict the mechanism of Atractylodes lancea in the treatment of diabetes by using the method of network pharmacology. [Methods] The active constituents of A. lancea were mined and their action targets were predicted by using TCMSP database, and the targets of diabetes were screened out by GeneCards, and OMIM databases. The "constituent-target-pathway-disease" network of A. lancea in the treatment of diabetes was constructed by using Cytoscape software. The target protein-related interaction network was constructed by STRING database, and the biological function annotation and pathway analysis of key targets were carried out. [Results] The 4 active constituents of A. lancea could treat diabetes by intervening in 47 targets, 95 GO biological processes and 116 main biological pathways. [Conclusions] The wogonin, NSC63551, 3β-acetoxy atractylone and β-carotene in A. lancea may regulate nuclear receptor activity, transcription factor activity (directly bind to the ligand-regulated sequence-specific DNA), steroid receptor, G protein-coupled amine receptor activity, sodium-chloride transporter activity, neurotransmitter receptor activity and other pharmacological effects, by mediating AGE-RAGE pathway, IL-17 pathway, PI3K-Akt pathway, p53 pathway, etc., so as to treat diabetes.

Key words Atractylodes lancea, Network pharmacology, Diabetes, Active constituents, Target

1 Introduction

Diabetes is a metabolic disease characterized by hyperglycemia, most of which is type 2 diabetes[1]. In recent years, with the change of life style and the aggravation of population aging, the prevalence rate of diabetes is increasing year by year[2]. The latest data show that China has become the country with the largest number of diabetes patients, and shows a trend even in the young[3]. Therefore, the discovery of effective drugs for the treatment of diabetes is still the focus of the current research.Atractylodeslanceawas first listed as the top medicine in theClassicofShennongMateriaMedica, and it is an important medicine for drying dampness and strengthening the spleen. It can be used for retention of dampness in the middle-heater and abdominal fullness and distention. Traditional Chinese medicine believes that the spleen deficiency and stagnation of phlegm-dampness is the pathogenesis of diabetes, soA.lanceais a commonly used traditional Chinese medicine in the treatment of diabetes. Modern studies have revealed the chemical composition and pharmacological effects ofA.lancea. It is reported thatA.lanceahas the pharmacological effects of lowering blood sugar, regulating lipid metabolism disorder and inhibiting α-glucosidase activity. The pharmacological mechanism ofA.lanceain the treatment of diabetes has been preliminarily revealed, but due to the complexity and diversity of chemical constituents in traditional Chinese medicine, the mechanism ofA.lanceain the treatment of diabetes is still unclear. Network pharmacology can construct a network of "active constituents of traditional Chinese medicine-action target-signaling pathway-therapeutic mechanism", which can systematically and comprehensively clarify the ways and pathways of active constituents of traditional Chinese medicine in the treatment of diseases. In this study, the target network of active constituents ofA.lanceaand the treatment of diabetes was constructed through the databases of TCMSP, STING, Genecards and OMIM, and the biological process and pathway enrichment analysis were carried out to provide theoretical support for elucidating the clinical treatment and experimental research ofA.lanceain the treatment of diabetes.

2 Data and methods

2.1 Screening of active constituents fromA.lanceaThrough the traditional Chinese medicine system pharmacology database and analysis platform (TCMSP, http:∥lsp.nwu.edu.cn/index.php), it was searched with cangzhu (A.lancea), the data of all constituents ofA.lanceaincluded in the database were mined, and a total of 49 compounds were collected. Then, based on the pharmacokinetic parameters, oral bioavailability (OB)≥30% and drug similarity (DL)≥0.18 were set as screening conditions to make pharmacokinetic screening of the collected compounds, and the compounds (the active constituents ofA.lancea) were obtained as the object of study[9].

2.2 Screening of common interaction targets forA.lanceaand diabetesThe target information of the active constituents ofA.lanceawas searched by TCMSP database, and the human gene name corresponding to the target was searched by Uniprot database (https:∥www.uniprot.org/). Then the related targets of diabetes were retrieved by Genecards database (https:∥www.genecards.org/) and OMIM database (https:∥www.omim.org/). After merging two databases and removing duplications, the targets related to the active constituents ofA.lanceaand disease targets were intersected by R language (https:∥www.rproject.org/) to obtain the targets of active constituents ofA.lanceafor the treatment of diabetes, and draw the Venn diagram.

2.3 Construction of drug-constituent-target-disease network

The common active constituents and common protein target genes ofA.lanceaand diabetes were introduced into the system by Cytoscape 3.7.2 (http:∥www.cytoscape.org), and the drug-constituent-target-disease network was constructed. The drug, active constituent and key target ofA.lanceain the network were represented by Node, and the drug-constituent, constituent-target and target-disease connections were represented by Edge.

2.4 Construction of key target protein-protein interaction (PPI) networkThe common target genes ofA.lanceaand diabetes were introduced into String database (Version 11.0) (https:∥string-db.org), and the "Multiple Proteins" function was selected. Set the species as Homosapiens, to get the protein interaction network; set the score>0.4, that is, construct the protein-protein interaction (PPI) network diagram, and obtain the node value and other information reflecting the relationship between the targets.

2.5 GO (gene ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysisR language was used to install Bioconductor platform-related packages (DOSE, clusterProfiler, pathview, ClusterProfiler,etc.), and Perl tool was used to convert the name of the key target ofA.lanceain the treatment of diabetes into Entrez ID. Set pvalue=0.05,qvalue=0.05 as the condition, to carry out GO enrichment analysis and KEGG enrichment analysis, output the results and draw barplot column chart and dotplot bubble chart.

3 Results and analysis

3.1 Screening of active constituents fromA.lancea49 active constituents ofA.lanceawere retrieved by TCMSP database, and then screened by OB>30% and DL>0.18. 9 potentially active constituents ofA.lanceawere obtained, as shown in Table 1.

Table 1 The active constituents of Atractylodes lancea and their OB and DL values

3.2 Prediction of potential targets of active constituents ofA.lanceain the treatment of diabetesThe target information of effective compounds ofA.lanceawas predicted by TCMSP database target prediction model. 67 targets of 4 active constituents ofA.lancea(wogonin, NSC63551, 3β-acetoxy atractylone, β-carotene) were predicted and screened, and the gene ID was annotated by Uniprot. The target genes of diabetes were searched by Genecards and OMIM databases, and the genes with correlation score greater than 5 were combined and a total of 13 999 disease targets were obtained after duplication removal. By mapping the target genes ofA.lanceaand diabetes, 47 common targets ofA.lanceaand diabetes were obtained, and the Venn diagram was drawn by R language (Fig.1). The common target genes ofA.lanceaand diabetes areNOS2,PTGS1,ESR1,AR,SCN5A,PPARG,PTGS2,RXRA,MAPK14,GSK3B,CHEK1,PRSS1,ADRB2,GABRA1,RELA,AKT1,CCND1,BCL2,CDKN1A,EIF6,BAX,CASP9,KDR,TNFSF15,JUN,IL6,CASP3,TP63,BBC3,TEP1,MMP1,CCL2,PRKCD,PTGER3,FN1,CXCL8,MCL1,PGR,CHRM3,CHRM1,ACHE,SLC6A2,ADRA1A,CHRM2,SLC6A3,SLC6A4,OPRM1. This showed thatA.lanceacould play a role in the treatment of diabetes through multiple targets.

Fig.1 Intersection of diabetes targets and active constituents targets of Atractylodes lancea

3.3 Drug-constituent-target-disease network construction ofA.lanceain the treatment of diabetesThe active constituents ofA.lanceaand their therapeutic targets in the treatment of diabetes were visualized by Cytoscape 3.7.2, as shown in Fig.2.

Fig.2 Drug-constituent-target-disease network of Atractylodes lancea in the treatment of diabetes

3.4 PPI network analysis of key targets ofA.lanceain treating diabetes47 target genes ofA.lanceaand diabetes were introduced into String database, and the confidence score was set to be more than 0.4. The PPI network diagram was obtained (Fig.3). What’s hidden is free protein, the blue line represents the evidence of gene coevolution, the red line represents the evidence of gene fusion, and the yellow line represents the evidence of text mining. The network consists of 47 nodes and 295 edges, with an average value of 12.6. The interacting proteins with scores≥0.99 are CDKN1A-CCND1, AKT1-GSK3B, RXRA-PPARG, MCL1-BAX, JUN-MAPK14, AKT1-CDKN1A, AKT1-CASP9, AKT1-ESR1, ESR1-CCND1 and GSK3B-CCND1. The R language was used to extract the information bar chart of the key targets in the network (Fig.4). The results showed that the values of AKT1, IL6, CASP3, JUN, CCND1, PTGS2, RELA, CXCL8, ESR1, MAPK14 and CDKN1A were high, indicating that these targets play a significant role in the network.

Fig.4 Key target information bar chart

3.5 Biological function and pathway analysis of key targets

With R language as the platform, the signaling pathway enrichment analysis was carried out by using the program package in Bioconductor and the GO annotation information and KEGG pathway database.

The results of GO annotation showed that a total of 95 GO biological processes were obtained, and the top biological functions were selected (P<0.001), mainly including nuclear receptor activity (5 targets), transcription factor activity (directly bind to the ligand-regulated sequence-specific DNA) (5 targets), steroid receptor (5 targets), G protein coupled amine receptor activity (5 targets), sodium chloride transporter activity (3 targets), cation[chlorine transporter activity (3 targets), neurotransmitter receptor activity (5 targets)], anion[(cationic transporter activity (3 targets), protease binding (5 targets)], acetylcholine receptor activity (3 targets), protein phosphatase binding (5 targets), ammonium binding (4 targets), neurotransmitter[(sodium transporter activity (3 targets), RNA polymerase II transcription factor binding (5 targets), ATP synthase binding (4 targets)]. This showed that the active constituents ofA.lanceacould play a role in the treatment of diabetes by regulating a variety of biological pathways (Fig.5).

Fig.5 GO biological process enrichment analysis of key targets of Atractylodes lancea-diabetes

The KEGG pathway was enriched withP<0.05 and the number of genes as screening conditions. The results showed that 47 target proteins ofA.lanceaanti-diabetic active constituent-target network involved 116 signaling pathways, of which 68 were disease pathways (such as small cell lung cancer), colorectal cancer endocrine resistance, insulin resistance; 48 were functional signaling pathways (such as AGE-RAGE pathways in diabetic complications), IL-17 signaling pathway, PI3K-Akt PI3K-Akt signaling pathway, p53 signaling pathway, FoxO signaling pathway, NF-kappa B signaling pathway, AMPK signaling pathway, MAPK signaling pathway, adipocytokine signaling pathway, PPAR signaling pathway, oxytocin signaling pathway, salivary secretion, GnRH signaling pathway) (Fig.6).

Fig.6 KEGG pathway enrichment analysis of key targets of Atractylodes lancea-diabetes

4 Discussion

The multi-constituents and multi-targets of traditional Chinese medicine have unique advantages in the prevention and treatment of chronic diseases such as diabetes. Studies have shown thatA.lanceahas chemical constituents such as sesquiterpenes, enynes, triterpenes, steroids and aromatic glycosides, and has pharmacological effects such as inhibition of gastric acid secretion, promotion of gastrointestinal motility and gastric emptying, blood sugar lowering, anti-bacteria and anti-inflammation, cardiovascular protection and nervous system. The effective substances and mechanism ofA.lanceaagainst diabetes have not been fully elucidated. In this study, the main active constituents and possible molecular mechanism ofA.lanceain the treatment of diabetes were predicted by network pharmacology. It was found that the main active constituents ofA.lanceain the treatment of diabetes were wogonin, NSC63551, 3β-acetoxy atractylone and β-carotene. Modern studies have confirmed that wogonin can reduce fasting blood glucose and promote skeletal muscle utilization of glucose in type 2 diabetic mice[10], and improve retinopathy in type 2 diabetic mice[11]. β-carotene can significantly reduce blood glucose in type 2 diabetic rats, and it can be combined with magnesium to improve glucose and lipid metabolism and reduce insulin resistance[12].

From the antidiabetic active constituent-target network, it was known that the 4 active constituents ofA.lanceahad an effect on 47 targets. In recent years, it has been found that PI3K/AKT plays an important role in the regulation of glucose transport, glycogen synthesis, glycolysis and gluconeogenesis, as well as protein synthesis and fat decomposition[13]. Studies have also shown that inflammation is one of the important factors inducing type 2 diabetes[14], in which IL-6 can promote liver to synthesize acute phase proteins such as C-reactive protein and promote inflammation[15]. Apoptosis is a way of spontaneous cell death. Insufficient insulin secretion caused by islet cell apoptosis is an important cause of type 1 diabetes[16]. CASP3 plays an irreplaceable role in cell apoptosis. JNK (c-Jun) signal transduction pathway is an important branch of MAPK pathway, which plays an important role in many physiological and pathological processes such as cell cycle, reproduction, apoptosis and cell stress. Studies have shown that the JNK gene can induce inflammation that leads to diabetes when driven by a high-fat diet. Some of these studies indicate the feasibility of network pharmacology to predict the antidiabetic targets and pathways ofA.lancea. The key targets such as AKT1, IL6, CASP3, JUN, CCND1, PTGS2, RELA, CXCL8, ESR1, MAPK14 and CDKN1A can be used as the potential targets ofA.lanceato reveal its mechanism.

The results of GO enrichment analysis were used to predict 95 anti-diabetic biological processes ofA.lancea, in whichPvalues of nuclear receptor activity and transcription factor activity were the lowest. Modern studies have confirmed that nuclear receptors activate transcription factors and regulate cell growth and differentiation, which are closely related to the occurrence and development of diabetes, fatty liver and other diseases. Steroid hormone enters the nucleus and binds with steroid receptor, which affects the activity and function of nucleus, while the increase of secretion of endogenous adrenocortical hormone or improper use of exogenous GC can induce steroid diabetes[17]. Activation of G protein coupled receptor (GPR) helps islet cells secrete insulin and enhance the body’s sensitivity to insulin[18]. It can be seen that the prediction results of GO enrichment analysis have confirmed several biological functions, and the prediction results can provide a reference for revealing the anti-diabetic mechanism ofA.lancea.

According to the enrichment analysis of KEGG pathway, the 47 target proteins of the antidiabetic active constituent-target network ofA.lanceawere mainly enriched in AGE-RAGE signaling pathway in diabetic complications, small cell lung cancer, human cytomegalovirus infection, Kaposi sarcoma-associated herpesvirus infection, colorectal cancer, IL-17 signaling pathway, measles, hepatitis B, PI3K-Akt signaling pathway, p53 signaling pathway, Epstein-Barr virus infection, Yersinia infection, apoptosis, endocrine resistance, prostate cancer, EGFR tyrosine kinase inhibitor resistance, insulin resistance,etc. Among them, AGE-RAGE pathway had the lowestPvalue, which may be the main pathway ofA.lanceaanti-diabetes. Studies have shown that AGE is the main induced product of hyperglycemia and oxidative stress in type 2 diabetes. It interacts with RAGE, changes the function of protein, activates a series of intracellular signal transduction pathways, produces multiple pathological cellular responses, and promotes the formation and development of type 2 diabetes and its complications[19-20]. This also points out a direction for the next step to study the anti-diabetic mechanism ofA.lanceathrough animal experiments.

To sum up, this study mined the main active constituents and target genes ofA.lanceaand the mechanism of diabetes through the method of network pharmacology. The results showed that The wogonin, NSC63551, 3β-acetoxy atractylone and β-carotene inA.lanceamay regulate nuclear receptor activity, transcription factor activity (directly bind to the ligand-regulated sequence-specific DNA), steroid receptor, G protein-coupled amine receptor activity, sodium-chloride transporter activity, neurotransmitter receptor activity and other pharmacological effects, by mediating AGE-RAGE pathway, IL-17 pathway, PI3K-Akt pathway, p53 pathway,etc., so as to treat diabetes. The above results can provide new ideas for the treatment of diabetes. However, at present, the information collected in the database is not comprehensive, the screening process of active drug constituents and their targets will be affected by the subjective attitude of researchers, and the metabolic process of active drug constituents in the body is also affected by many factors, therefore, the results of this study will have some limitations, and the above-mentioned mechanism ofA.lanceain the treatment of diabetes needs to be verified by experiments.


登录APP查看全文